InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by GILL JOHN. Director active across 1 company, notably Altimmune, Inc.. In total, 2 filings have been published. Split: 1 buy · 1 sell. Total volume traded: €83k. History available since 12 August 2022. The latest transaction was filed on 23 December 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations